PAVmed Inc. (PAVM) stock
PAVMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.51−0.24 (-13.71%)
Close on Nov 17, 2026Market cap $12.07MP/E –Yield –
Earnings
PAVmed's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Mar 29, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$41.00K
+720.0% on a year earlier
non-GAAP adjusted net loss per common share, Q3 FY2026
-$0.19
-$0.02 a year earlier
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of PAVmed's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 29, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 13, 2026before the open | $41.00K | +720.0% | – | -$0.19 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 14, 2026before the open | $33.00K | +450.0% | -$0.87 | -$0.27 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 15, 2026before the open | $22.00K | +175.0% | -$4.42 | -$1.17 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 30, 2026before the open | $52.00K | +420.0% | -$2.05 | -$1.05 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 13, 2025before the open | $5.00K | -99.5% | -$0.29 | -$0.02 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 14, 2025before the open | $6.00K | -99.4% | -$0.74 | -$0.05 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 15, 2025before the open | $8.00K | -99.2% | $0.34 | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 25, 2025before the open | $10.00K | – | $0.12 | -$0.06 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 14, 2024before the open | $1.00M | +25.0% | $1.44 | -$0.54 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 13, 2024before the open | $1.00M | – | -$1.19 | -$0.84 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 14, 2024before the open | $1.00M | – | -$2.62 | -$0.99 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 15, 2023after the close | $800.00K | +700.0% | -$0.16 | -$0.09 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 15, 2023before the open | $100.00K | -66.7% | -$0.23 | -$0.15 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 15, 2022during market hours | $100.00K | – | -$0.29 | -$0.15 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 17, 2022during market hours | – | – | -$0.29 | -$0.17 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 12, 2022during market hours | $200.00K | – | -$0.20 | -$0.14 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 29, 2022during market hours | $300.00K | – | -$0.20 | -$0.15 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 4, 2021during market hours | – | – | – | – | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 12, 2021during market hours | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 17, 2021during market hours | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 22, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 17, 2020during market hours | – | – | – | – | Filing |
| Q2 FY2020ended Jun 30, 2020 | Aug 18, 2020during market hours | – | – | – | – | Filing |
| Q1 FY2020ended Mar 31, 2020 | May 21, 2020during market hours | – | – | – | – | Filing |
| Q1 FY2019ended Mar 31, 2019 | May 8, 2019before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
PAVmed has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When PAVmed puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases PAVmed filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Update
- Update
- Results
- Results
- Results
- Results
- Results
- Update
- Update
- Results
- Results
See a number that looks wrong?